The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: RS1 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000330.4(RS1):c.76G>A (p.Glu26Lys)

CA10360819

741219 (ClinVar)

Gene: RS1
Condition: X-linked retinoschisis
Inheritance Mode: X-linked inheritance
UUID: 3b7924ec-034f-46c4-bf24-8513eab3f55c
Approved on: 2025-05-19
Published on: 2025-05-20

HGVS expressions

NM_000330.4:c.76G>A
NM_000330.4(RS1):c.76G>A (p.Glu26Lys)
NC_000023.11:g.18657642C>T
CM000685.2:g.18657642C>T
NC_000023.10:g.18675762C>T
CM000685.1:g.18675762C>T
NC_000023.9:g.18585683C>T
NG_008659.3:g.24807G>A
ENST00000379984.4:c.76G>A
ENST00000379984.3:c.76G>A
NM_000330.3:c.76G>A
More

Benign

Met criteria codes 1
BA1
Not Met criteria codes 2
PP3 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
X-linked Inherited Retinal Disease VCEP
The NM_000330.4(RS1):c.76G>A variant is a missense variant encoding the substitution of Glutamic acid with Lysine at amino acid 26. This variant is present in gnomAD v.4.1.0. at a frequency of 0.0004493 among hemizygous individuals, with 174 variant alleles / 387285 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.0002 (BA1). The computational predictor REVEL gives a score of 0.491, which is between the ClinGen X-linked IRD VCEP thresholds of >0.664 and <0.290 and does not predict a damaging effect on RS1 function. Additionally, the splicing impact predictor SpliceAI gives a score of 0.03 (Acceptor Gain), which is below the ClinGen X-linked IRD VCEP recommended threshold of >0.2 and does not strongly predict an impact on splicing. As a result, the BP4 and PP3 codes were not met. In summary, this variant is classified as benign for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: BA1. (date of approval 01/24/2025).
Met criteria codes
BA1
This variant is present in gnomAD v.4.1.0. at a frequency of 0.0004493 among hemizygous individuals, with 174 variant alleles / 387285 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.0002 (BA1).
Not Met criteria codes
PP3
The computational predictor REVEL gives a score of 0.491, which is below the ClinGen X-linked IRD VCEP threshold of >0.664 and does not predict a damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a score of 0.03 (Acceptor Gain), which is below the ClinGen X-linked IRD VCEP recommended threshold of >0.2 and does not strongly predict an impact on splicing.
BP4
The computational predictor REVEL gives a score of 0.491, which is above the ClinGen X-linked IRD VCEP threshold of <0.290 and does not predict a non-damaging effect on RS1 function.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.